Is what we do FDA approved? Is stem cell therapy a cure for anything? How do you know what's going on in the confusing landscape of regenerative medicine? In this episode, Dr. Oltman reviews the regulatory landscape in regenerative medicine from the FDA to the FTC. There is a lot of confusion of terms and definitions, as well as stances that shift and change with time. Ultimately, it's not necessarily important for a potential-patient to know every detail but it is important to know the general outline and how to spot red-flags. 

Ver todos los episodios